These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Study of hospitalizations for pneumococcal pneumoniae in Centre region, 2004-2008]. Grammatico-Guillon L; Thiercelin N; Mariani S; Lecuyer AI; Goudeau A; Bernard L; Rusch E Rev Epidemiol Sante Publique; 2012 Feb; 60(1):1-8. PubMed ID: 22245493 [TBL] [Abstract][Full Text] [Related]
43. Compliance with influenza and pneumococcal vaccination among patients with chronic obstructive pulmonary disease consulting their medical practitioners in Catalonia, Spain. Jiménez-García R; Ariñez-Fernandez MC; Hernández-Barrera V; Garcia-Carballo MM; de Miguel AG; Carrasco-Garrido P J Infect; 2007 Jan; 54(1):65-74. PubMed ID: 17049991 [TBL] [Abstract][Full Text] [Related]
45. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children. Madhi SA; Kuwanda L; Cutland C; Klugman KP Clin Infect Dis; 2005 May; 40(10):1511-8. PubMed ID: 15844075 [TBL] [Abstract][Full Text] [Related]
46. Pneumococcal pneumonia in hospitalized Uruguayan children and potential prevention with different vaccine formulations. Hortal M; Sehabiague G; Camou T; Iraola I; Estevan M; Pujadas M J Pediatr; 2008 Jun; 152(6):850-3. PubMed ID: 18492530 [TBL] [Abstract][Full Text] [Related]
48. [Antipneumococcal vaccine: up date and prospective]. Caramia G; Pastorelli G Minerva Pediatr; 2005 Oct; 57(5):229-41. PubMed ID: 16205607 [TBL] [Abstract][Full Text] [Related]
49. Non-response to specific serotypes likely cause for failure to 23-valent pneumococcal polysaccharide vaccine in the elderly. Ortqvist A; Henckaerts I; Hedlund J; Poolman J Vaccine; 2007 Mar; 25(13):2445-50. PubMed ID: 17052816 [TBL] [Abstract][Full Text] [Related]
50. [Pneumococcal vaccination]. Léophonte P Rev Mal Respir; 1999 Nov; 16(5):763-6. PubMed ID: 10612144 [No Abstract] [Full Text] [Related]
51. Safety and immunogenicity of the American Academy of Pediatrics--recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients. Lin PL; Michaels MG; Green M; Mazariegos GV; Webber SA; Lawrence KS; Iurlano K; Greenberg DP Pediatrics; 2005 Jul; 116(1):160-7. PubMed ID: 15995047 [TBL] [Abstract][Full Text] [Related]
52. Immunogenicity, efficacy, safety and effectiveness of pneumococcal conjugate vaccines (1998-2006). Oosterhuis-Kafeja F; Beutels P; Van Damme P Vaccine; 2007 Mar; 25(12):2194-212. PubMed ID: 17267077 [TBL] [Abstract][Full Text] [Related]
53. The cost-burden of paediatric pneumococcal disease in Sweden and the potential cost-effectiveness of prevention using 7-valent pneumococcal vaccine. Silfverdal SA; Berg S; Hemlin C; Jokinen I Vaccine; 2009 Mar; 27(10):1601-8. PubMed ID: 19146905 [TBL] [Abstract][Full Text] [Related]
54. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Picazo JJ Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362 [TBL] [Abstract][Full Text] [Related]
55. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity. Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399 [TBL] [Abstract][Full Text] [Related]
56. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Peñaranda M; Falco V; Payeras A; Jordano Q; Curran A; Pareja A; Samperiz G; Dalmau D; Ribera E; Riera M Clin Infect Dis; 2007 Oct; 45(7):e82-7. PubMed ID: 17806042 [TBL] [Abstract][Full Text] [Related]
57. The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use. Toltzis P; Jacobs MR Infect Dis Clin North Am; 2005 Sep; 19(3):629-45. PubMed ID: 16102653 [TBL] [Abstract][Full Text] [Related]
58. Pneumococcal serogroups and serotypes in severe pneumococcal pneumonia in Belgian children: theoretical coverage of the 7-valent and 9-valent pneumococcal conjugate vaccines. De Schutter I; Malfroot A; Piérard D; Lauwers S Pediatr Pulmonol; 2006 Aug; 41(8):765-70. PubMed ID: 16779850 [TBL] [Abstract][Full Text] [Related]
59. Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects. Claes C; Reinert RR; von der Schulenburg JM Eur J Health Econ; 2009 Feb; 10(1):25-38. PubMed ID: 18379830 [TBL] [Abstract][Full Text] [Related]
60. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]